iBeaLee Dark Spot Corrector Cream

Manufacturer
Shenzhen Yikai Electronic Technology Co., Ltd.
Effective date
2023-12-27
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:05:47

Label at a glance#

ProductiBeaLee Dark Spot Corrector Cream
Active ingredientNIACINAMIDE
Label structure9 sections

Dosage and administration

Cleanse the application area and pat dry. Gently massage a thin layer into the affected area of skin until fully absorbed. Protect treated skin from sunlight by following up with an SPF 30+ sunscreen.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Niacinamide 5%

Purpose

OTC - PURPOSE SECTION

Dark Spot Corrector

Warnings

WARNINGS SECTION

WARNINGS:Keep out of reach of children. For external use only. Before using, test for sensitivity on a small area of skin.

Do not use

OTC - DO NOT USE SECTION

Do not use on damaged skin. Use only as directed. Avoid contact with eyes. Rinse with warm water to remove. Stop use and consult your physician if rash occurs. Do not ingest. If swallowed, get medical help or contact a Poison Control Center right away! Do not use if safety sealis broken or missing. Store in a cool, dry place.

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

Directions

DOSAGE & ADMINISTRATION SECTION

Cleanse the application area and pat dry. Gently massage a thin layer into the affected area of skin until fully absorbed. Protect treated skin from sunlight by following up with an SPF 30+ sunscreen.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Sunflower Oil, Caprylyl Caprylate/Caprate,Glycerin,Trideceth-6, Aloe Vera, Niacinamide, Glycyrrhiza Glabra Extract, Morus Alba Root Extract, Hydrolyzed Oat Protein,Ethyl Ascorbic Acid, Alpha Arbutin, Hyaluronic Acid, Phenoxyethanol,Green Tea Extract, Tetrapeptide-21, Potassium Sorbate, Citric Acid,Xanthan Gum, Tocopherol, Soy Isoflavones, Cistus Ladaniferus Oil,Lemon Essential Oil.

Use

INDICATIONS & USAGE SECTION

Remove dark spots on face.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

1122334455

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
83809-016-012025-01-30C16284748780-12cef2736-85d9-d83d-e063-dadaa90ab31f83809-016
83809-016-022025-01-30C16284748780-12cef2736-85d9-d83d-e063-dadaa90ab31f83809-016

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83809-016-01iBeaLee Dark Spot Corrector Cream20 g in 1 CANISTERCREAM201
83809-016-02iBeaLee Dark Spot Corrector Cream50 g in 1 CANISTERCREAM501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
83809-016IBEALEE DARK SPOT CORRECTOR CREAM CREAM [SHENZHEN YIKAI ELECTRONIC TECHNOLOGY CO., LTD.]12 package rows20231228_0d78fe3f-516b-6ef6-e063-6394a90a723e.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83809-01683809-016-01, 83809-016-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0d78fe3f-516c-6ef6-e063-6394a90a723e0d78fe3f-516b-6ef6-e063-6394a90a723e2023-12-27WarningsExact identifier
spl id: 0d78fe3f-516c-6ef6-e063-6394a90a723e
spl set id: 0d78fe3f-516b-6ef6-e063-6394a90a723e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.